Revision EpidA: Regulatory Impact Assessment - Part 1
- Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
- Total publications:0 publications
Grant number: 142004701
Grant search
Key facts
Disease
COVID-19Start & end year
20222023Known Financial Commitments (USD)
$125,427.97Funder
State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)Principal Investigator
Wäfler KarinResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Policy research and interventions
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
On June 19, 2020, the Federal Council commissioned the FDHA to start a partial revision of the Epidemics Act (EpG). The law is intended to enable the federal government and the cantons to work closely together to protect the health of the population from future threats from communicable diseases and to take the necessary precautionary measures in good time. The revised law addresses the findings from the implementation of the EpG before the Covid-19 pandemic, the findings from the Covid-19 response, but also new developments, e.g. with regard to digitalization. The regulatory impact assessment (RFA) is an instrument for examining and presenting the economic effects of federal proposals. This RFA examines the impact of the revised EpG.